Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study

Anemia is an inevitable complication of hemodialysis, and the primary cause is erythropoietin deficiency. After diagnosis, treatment begins with an erythropoiesis-stimulating agent (ESA). However, some patients remain anemic even after receiving this medication. This study aimed to investigate the f...

Full description

Bibliographic Details
Main Authors: E.J.F. Santos, E.V. Hortegal, H.O. Serra, J.S. Lages, N. Salgado-Filho, A.M. dos Santos
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2018-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000700603&lng=en&tlng=en